Featured Articles

CDI Researcher's Work Earns $1 Million Funding from Hyundai


CDI researcher Todd Druley, MD, PhD, was awarded a $1 million Quantum Award from nonprofit Hyundai Hope on Wheels (HHOW) to continue his focus on acute myeloid leukemia (AML). ...More

Molecules to Missiles


CDI funding tests the promise of nanomedicine in brain tumor treatment....More

Immune System: The Body's New Super Hero?


The journal Science Translational Medicine recently published a study showing promise for immunotherapy in treating recurrent acute myeloid leukemia (AML) in adults. The study’s lead author Rizwan Romee, MD, and senior author Todd Fehniger, MD, PhD, from the division of oncology of Washington University School of Medicine, barely let the ink dry before they were on to their next challenge. In collaboration with Jeffrey Bednarski, MD, PhD, pediatrics, they submitted a proposal to and received funding from the Children’s Discovery Institute to pursue the same study in children....More

Riding for Vivian


Vivian Keith is a feisty, sometimes stubborn 3-year-old with curly-cue hair and a twin brother named Lane. Her mom, Ginger, always knew Vivian was a determined little girl but she didn’t realize the depth of that determination until Vivian had to battle cancer....More

CDI Researchers Now Part of Pediatric Neuro-Oncology Consortium


When the Washington University School of Medicine joined the Pacific Pediatric Neuro-Oncology Consortium, it brought with it three CDI-funded physician-scientists who now have access to the most cutting-edge brain tumor therapies for the children of St. Louis and surrounding region. ...More

New Research on Pediatric Brain Tumors Underway


According to Dr. Rubin, MD, PhD, pediatrics, despite decades of research, we still have little understanding of the fundamental mechanisms that drive the genesis of pediatric brain tumors and the requirements for effective treatment. Now, the discovery of a key player in making brain tumors resistant to treatment by Washington University School of Medicine’s Albert Kim, MD, PhD, neurosurgery, will inform a CDI study that brings Dr. Kim together with Dr. Rubin, developmental biologist Kristen Kroll, PhD, and Hiroko Yano, PhD, an expert in neuro-epigenetics, as co-principal investigators to crack the code of what happens during brain stem cell differentiation that sets a child on the path to developing this malignant brain tumor. ...More

Inspired by a Superhero


Learn about how one little brave little boy's cancer fight inspires our pediatric cancer research seeking answers for a devastating diagnosis....More

Pedal the Cause for Pediatric Cancer Research


Private support for pediatric cancer research has never been more critical. And, you can make a difference....More

A Tale of Two Leukemias


Two stories of struggle and survival, two CDI researchers looking for answers....More

Infants With Leukemia Inherit Susceptibility


CDI-funded research, presented at the 2013 CDI Investor Symposium and recently published in the online journal Leukemia, indicates that babies with leukemia have inherited a genetic predisposition that makes them highly susceptible to the disease. ...More

1 2 3
Increase font-size Restore default font-sizes Decrease font-sizeFONT SIZE
Bookmark and Share